GGrantIndex
← Leaderboards

Claudine Isaacs

Georgetown University

$8,250,667
Attributed
$8,250,667
Total exposure
19
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$8,250,667 · 19

By mechanism

N01$4,042,302 · 1
U24$2,810,445 · 1
M01$1,045,130 · 15
P30$352,790 · 2

Top collaborators

No co-investigators on record.

Most similar at Georgetown University

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelCancer RiskClinical ResearchFundingParticipantMalignant NeoplasmsResourcesGrantHuman SubjectProgramsInstitutionWomanCancer DiagnosisSiteQuestionnairesBaseComputer Retrieval Of Information On Scientific Projects DatabaseNeoplasm /Cancer GeneticsSourceUnited States National Institutes Of HealthOperative Surgical ProceduresFutureCancer PreventionDesign

Grant awards (33)

Protocol Review and Monitoring System$62,786
P30 · FY2021 · CA · contact PI
Shared Resource - Survey, Recruitment, & Biospecimen Shared Resource$82,216
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$62,786
P30 · FY2020 · CA · contact PI
Shared Resource - Survey, Recruitment, & Biospecimen Shared Resource$82,216
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$62,786
P30 · FY2019 · CA · contact PI
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial$906,613
N01 · FY2010 · CA · contact PI
National Lung Screening Trial (NLST)$604,409
N01 · FY2010 · CA · contact PI
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial$649,306
N01 · FY2009 · CA · contact PI
National Lung Screening Trial (NLST)$420,380
N01 · FY2009 · CA · contact PI
THE FAMILIAL CANCER REGISTRY$168,344
M01 · FY2009 · RR · contact PI
A TRIAL OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH DCIS OR AT HIGH RISK FOR INVA$31,079
M01 · FY2009 · RR · contact PI
THE FAMILIAL CANCER REGISTRY$94,888
M01 · FY2008 · RR · contact PI
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RIS WOMEN$21,403
M01 · FY2008 · RR · contact PI
PROSTATE, LUNG, COLORECTAL & OVARIAN CANCER SCREENING TRIAL - SCREEN$1,461,594
N01 · FY2007 · CA · contact PI
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RIS WOMEN$127,765
M01 · FY2007 · RR · contact PI
THE FAMILIAL CANCER REGISTRY$49,263
M01 · FY2007 · RR · contact PI
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RISK WOMEN$26,274
M01 · FY2007 · RR · contact PI
THE FAMILIAL CANCER REGISTRY$10,967
M01 · FY2007 · RR · contact PI
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RIS WOMEN$173,469
M01 · FY2006 · RR · contact PI
CANCER GENETICS NETWORK$81,949
U24 · FY2006 · CA · contact PI
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RISK WOMEN$129,430
M01 · FY2005 · RR
CANCER GENETICS NETWORK$48,545
U24 · FY2005 · CA
CALGB 79809: PHASE III TRIAL OF INTRAVENOUS ZOLEDRONIC ACID (ZOMETA?)$7,765
M01 · FY2005 · RR
NOVEL THERAPEUTIC AGENTS (CELECOXIB) AGAINST BREAST CANCER:PHASE II TRIAL DESIGN$3,396
M01 · FY2005 · RR
CANCER GENETICS NETWORK$363,003
U24 · FY2004 · CA
Cancer Genetics Network ovarian cancer screening pilot trial in high risk women$191,265
M01 · FY2004 · RR
CGN/IBMC breast cancer screening pilot trial in high ris$9,120
M01 · FY2004 · RR
A pilot study to detect early changes by FDG-PET scan and in ductal lavage cells$702
M01 · FY2004 · RR
CANCER GENETICS NETWORK$481,642
U24 · FY2003 · CA
CANCER GENETICS NETWORK$806,081
U24 · FY2002 · CA
CANCER GENETICS NETWORK$415,322
U24 · FY2001 · CA
CANCER GENETICS NETWORK$125,565
U24 · FY2001 · CA
CANCER GENETICS NETWORK$488,338
U24 · FY2000 · CA